Gilead Sciences Canada, Inc. (Gilead Canada) is the Canadian affiliate of Gilead Sciences, Inc. and was established in Ontario, in 2006. With 21 marketed products, we work in the therapeutic areas of HIV, liver disease, oncology, inflammatory diseases and respiratory diseases supporting full-scale commercial, medical, regulatory, finance and legal operations for both Gilead Sciences and Kite, a Gilead Company, in Canada.
We have endeavored to support Canada’s goal of creating a vibrant life sciences sector, investing significantly across our operations.
Gilead has approximately 500 employees across Canada, supporting our pharmaceutical business that provides Canadians with access to our medications and the global development of new, innovative therapies at our research and process manufacturing facility in Edmonton, Alberta.
Manufacturing in Canada
Gilead’s Alberta facility is involved in the development of most of our small molecule programs and provides active ingredients for Gilead’s worldwide research programs.
Gilead also leverages Canadian contract manufacturing capabilities to serve both local and global production. One-third of worldwide Gilead tablet requirements are produced via Canadian contract manufacturing.